GTEx Vagina 20-29 vs 50-59 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Vagina 20-29 vs 50-59 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Vagina 20-29 vs 50-59 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Vagina 20-29 vs 50-59 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Vagina 20-29 vs 50-59 Down.

Results found

Linked to

 

Label

Description

 

Gene

urothelial cancer associated 1

Gene

long intergenic non-protein coding RNA 707

Gene

WAP four-disulfide core domain 21, pseudogene

Gene

LHFPL3 antisense RNA 2

Gene

KRT7 antisense RNA 1

Gene

GATA3 antisense RNA 1

Gene

long intergenic non-protein coding RNA 1559

Gene

gastric cancer associated transcript 2

Gene

guanylate cyclase 1 soluble subunit beta 2 (pseudogene)

Gene

NR4A1 antisense RNA

  • Gene

    urothelial cancer associated 1


  • Gene

    long intergenic non-protein coding RNA 707


  • Gene

    WAP four-disulfide core domain 21, pseudogene


  • Gene

    LHFPL3 antisense RNA 2


  • Gene

    KRT7 antisense RNA 1


  • Gene

    GATA3 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 1559


  • Gene

    gastric cancer associated transcript 2


  • Gene

    guanylate cyclase 1 soluble subunit beta 2 (pseudogene)


  • Gene

    NR4A1 antisense RNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.